Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human/Feline CXCL12/SDF-1 beta (aa 19-93)
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 2716SD025
This item is not returnable.
View return policy
Description
The Recombinant Human/Feline CXCL12/SDF-1 beta (aa 19-93) is derived from E. coli. The Recombinant Human/Feline CXCL12/SDF-1 beta (aa 19-93) has been validated for the following applications: Bioactivity.Specifications
| Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein. | |
| 8.8 kDa | |
| 25 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Recombinant |
| 6387 | |
| CXCL12/SDF-1 beta aa 19-93 | |
| E. coli-derived CXCL12/SDF-1 beta protein Ser19-Met93 | |
| Unconjugated | |
| 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction